This study proposes a cross-species transcriptomic framework to predict vaccine reactogenicity, with implications for preclinical vaccine safety assessment. The findings show that mouse muscle ...

A 67-year-old Siliguri resident, after prostate cancer treatment, embraced Ayurveda and yoga for recovery. Within months, his ...

Anifrolumab, a type I interferon receptor antagonist, is already approved as an intravenous (IV) therapy for SLE. The TULIP-SC trial was designed to evaluate whether a weekly subcutaneous (SC) ...

The original ruling did not permanently bar the comptroller from auditing the events of October 7, but temporarily froze work on eight defined “core” audits while ...

A Division Bench comprising Chief Justice DK Upadhyaya and Justice Tejas Karia issued notice to the Union of India through the Ministry of Finance, the Reserve Bank of India (RBI), and the National ...

Novo Nordisk advanced coramitug into the Phase III CLEOPATTRA trial, evaluating 1,280 patients with amyloid transthyretin cardiomyopathy or ATTR-CM. This decision was informed by results from their ...

Researchers suggest a vaccine could replace multiple jabs every year for seasonal respiratory infections and be on hand in the event of a new pandemic.

The Delhi High Court has sought a response from the Centre, RBI, and NPCI on a PIL demanding a stronger regulatory framework against rising UPI fraud. The plea, filed by a victim, highlights systemic ...

Because permeation and plasma-induced degradation are continuous rather than episodic, their effects accumulate gradually. There may be no excursion event, no sudden leak, and no particle spike to ...

From gua sha to Notox, Traditional Chinese medicine beauty links glow and longevity; learn how this slow, systemic approach is reshaping routines today.

And how to apply its ancient teachings to your regimen ...

Moderna says its experimental mRNA influenza vaccine, mRNA-1010, showed more than 30% greater relative vaccine efficacy against influenza A than a licensed egg-based flu shot in a large Phase 3 trial ...